BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 27416567)

  • 1. Acquired red blood cell alloantibodies in transfused patients of 80 years or over: a 2008-2013 national haemovigilance survey.
    Moncharmont P; Barday G; Py JY; Meyer F;
    Blood Transfus; 2017 May; 15(3):254-258. PubMed ID: 27416567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Haemolytic transfusion reactions caused by non-ABO red cell antibodies reported to the Norwegian Haemovigilance System 2004-2020.
    Espinosa A; Steinsvåg CT; Flesland Ø
    Vox Sang; 2024 May; 119(5):483-489. PubMed ID: 38373854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan.
    Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T
    Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Red-blood-cell alloimmunisation in relation to antigens' exposure and their immunogenicity: a cohort study.
    Evers D; Middelburg RA; de Haas M; Zalpuri S; de Vooght KM; van de Kerkhof D; Visser O; Péquériaux NC; Hudig F; Schonewille H; Zwaginga JJ; van der Bom JG
    Lancet Haematol; 2016 Jun; 3(6):e284-92. PubMed ID: 27264038
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Red blood cell alloimmunisation after platelet transfusion (excluding ABO blood group system).
    Moncharmont P
    Transfus Clin Biol; 2020 Aug; 27(3):185-190. PubMed ID: 32544526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfused platelets enhance alloimmune responses to transfused KEL-expressing red blood cells in a murine model.
    Madrid DJ; Santhanakrishnan M; Liu J; Gibb DR; Liu D; Natarajan P; Beitler D; Shi Z; Mo C; Tormey CA; Patel SR; Stowell SR; Hendrickson JE
    Blood Transfus; 2019 Sep; 17(5):368-377. PubMed ID: 30418129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An overview of red blood cell and platelet alloimmunisation in transfusion.
    Garraud O; Chiaroni J
    Transfus Clin Biol; 2022 Nov; 29(4):297-306. PubMed ID: 35970488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Red blood cell immunization in haemoglobinopathie: about 84 cases].
    Ben Amor I; Louati N; Khemekhem H; Dhieb A; Rekik H; Mdhaffar M; Gargouri J
    Transfus Clin Biol; 2012 Dec; 19(6):345-52. PubMed ID: 23103424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes.
    Moncharmont P; Quittançon E; Barday G; Benamara A;
    Vox Sang; 2019 May; 114(4):349-354. PubMed ID: 30818416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenging the dogma: Red blood cell-directed autoimmunity as risk factor for red blood cell alloimmunisation after blood transfusion.
    Oud JA; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; van der Bom JG; Evers D; Zwaginga JJ
    Br J Haematol; 2024 May; 204(5):2103-2111. PubMed ID: 38494337
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Red blood cell alloimmunisation in transfusion-dependent thalassaemia: a systematic review.
    Franchini M; Forni GL; Marano G; Cruciani M; Mengoli C; Pinto V; De Franceschi L; Venturelli D; Casale M; Amerini M; Capuzzo M; Grazzini G; Masiello F; Pati I; Veropalumbo E; Vaglio S; Pupella S; Liumbruno GM
    Blood Transfus; 2019 Jan; 17(1):4-15. PubMed ID: 30653458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The erythrocyte alloimmunisation in patients with sickle cell anaemia: a systematic review.
    da Cunha Gomes EG; Machado LAF; de Oliveira LC; Neto JFN
    Transfus Med; 2019 Jun; 29(3):149-161. PubMed ID: 29845661
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Red blood cell alloimmunisation in 18 to 50-year old transfused women: a 3-year study.
    Moncharmont P; Barday G; Meyer F
    Blood Transfus; 2015 Apr; 13(2):345-6. PubMed ID: 25369605
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is the research of posttransfusional alloantibodies still relevant?].
    Le Niger C; André C; Bourcier V; Augey L; Bazin A; Berger E; Betbeze V; Damais-Cepitelli A; Daurat G; De Meyer E; Ducroz S; Gouezec H; Huchet C; Lassale B; Leo-Kodeli S; Lovi V; Puntous M; Pujol S; Renom P; Rieux C
    Transfus Clin Biol; 2018 Feb; 25(1):8-13. PubMed ID: 29273503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease.
    Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H
    Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human leucocyte antigen alloimmunisation in repeatedly transfused thalassemic Egyptian children and its relation to febrile non-haemolytic transfusion reactions.
    Mourad Z; Hassab H; Younan D; Abdo A
    Transfus Med; 2015 Dec; 25(6):380-4. PubMed ID: 26578338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of extended c, E and K matching in females under 45 years of age on the incidence of transfusion-induced red blood cell alloimmunisation.
    Oud JA; Evers D; de Haas M; de Vooght KMK; van de Kerkhof D; Som N; Péquériaux NCV; Hudig F; Albersen A; van der Bom JG; Zwaginga JJ
    Br J Haematol; 2021 Nov; 195(4):604-611. PubMed ID: 34346067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study of alloimmunization against red cell antigens in sickle cell disease & thalassaemia major patients on regular red cell transfusion.
    Jariwala K; Mishra K; Ghosh K
    Indian J Med Res; 2019 Jan; 149(1):34-40. PubMed ID: 31115372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Red blood cell alloimmunisation among Chinese patients with β-thalassaemia major in Taiwan.
    Chao YH; Wu KH; Lu JJ; Shih MC; Peng CT; Chang CW
    Blood Transfus; 2013 Jan; 11(1):71-4. PubMed ID: 22790261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohematologic study and transfusion approach to patients with public antibodies].
    Solves P; de la Rubia J; Arriaga F; Cervera J; Arnao M; Carpio N; Marty ML
    Sangre (Barc); 1997 Feb; 42(1):25-9. PubMed ID: 9229799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.